These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

563 related items for PubMed ID: 20386446

  • 1. Prevention of parenteral nutrition-associated liver disease: lipid minimization.
    Cober MP, Teitelbaum DH.
    Curr Opin Organ Transplant; 2010 Jun; 15(3):330-3. PubMed ID: 20386446
    [Abstract] [Full Text] [Related]

  • 2. Prevention of parenteral nutrition-associated liver disease: role of omega-3 fish oil.
    Fallon EM, Le HD, Puder M.
    Curr Opin Organ Transplant; 2010 Jun; 15(3):334-40. PubMed ID: 20503524
    [Abstract] [Full Text] [Related]

  • 3. Fish oil-based lipid emulsions prevent and reverse parenteral nutrition-associated liver disease: the Boston experience.
    de Meijer VE, Gura KM, Le HD, Meisel JA, Puder M.
    JPEN J Parenter Enteral Nutr; 2009 Jun; 33(5):541-7. PubMed ID: 19571170
    [Abstract] [Full Text] [Related]

  • 4. Parenteral fish oil monotherapy in the management of patients with parenteral nutrition-associated liver disease.
    de Meijer VE, Gura KM, Meisel JA, Le HD, Puder M.
    Arch Surg; 2010 Jun; 145(6):547-51. PubMed ID: 20566974
    [Abstract] [Full Text] [Related]

  • 5. Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease.
    Gura KM, Lee S, Valim C, Zhou J, Kim S, Modi BP, Arsenault DA, Strijbosch RA, Lopes S, Duggan C, Puder M.
    Pediatrics; 2008 Mar; 121(3):e678-86. PubMed ID: 18310188
    [Abstract] [Full Text] [Related]

  • 6. Some new insights in intestinal failure-associated liver disease.
    Goulet O, Joly F, Corriol O, Colomb-Jung V.
    Curr Opin Organ Transplant; 2009 Jun; 14(3):256-61. PubMed ID: 19444108
    [Abstract] [Full Text] [Related]

  • 7. Pediatric parenteral nutrition-associated liver disease and cholestasis: Novel advances in pathomechanisms-based prevention and treatment.
    Orso G, Mandato C, Veropalumbo C, Cecchi N, Garzi A, Vajro P.
    Dig Liver Dis; 2016 Mar; 48(3):215-22. PubMed ID: 26698410
    [Abstract] [Full Text] [Related]

  • 8. Elimination of soybean lipid emulsion in parenteral nutrition and supplementation with enteral fish oil improve cholestasis in infants with short bowel syndrome.
    Rollins MD, Scaife ER, Jackson WD, Meyers RL, Mulroy CW, Book LS.
    Nutr Clin Pract; 2010 Apr; 25(2):199-204. PubMed ID: 20413701
    [Abstract] [Full Text] [Related]

  • 9. Supplemental Parenteral Vitamin E Into Conventional Soybean Lipid Emulsion Does Not Prevent Parenteral Nutrition-Associated Liver Disease in Full-Term Neonatal Piglets.
    Muto M, Lim D, Soukvilay A, Field C, Wizzard PR, Goruk S, Ball RO, Pencharz PB, Mi S, Curtis J, Wales PW, Turner JM.
    JPEN J Parenter Enteral Nutr; 2017 May; 41(4):575-582. PubMed ID: 26471989
    [Abstract] [Full Text] [Related]

  • 10. Intravenous fat emulsions reduction for patients with parenteral nutrition-associated liver disease.
    Cober MP, Killu G, Brattain A, Welch KB, Kunisaki SM, Teitelbaum DH.
    J Pediatr; 2012 Mar; 160(3):421-7. PubMed ID: 21982303
    [Abstract] [Full Text] [Related]

  • 11. Provision of a soy-based intravenous lipid emulsion at 1 g/kg/d does not prevent cholestasis in neonates.
    Nehra D, Fallon EM, Carlson SJ, Potemkin AK, Hevelone ND, Mitchell PD, Gura KM, Puder M.
    JPEN J Parenter Enteral Nutr; 2013 Jul; 37(4):498-505. PubMed ID: 22767698
    [Abstract] [Full Text] [Related]

  • 12. Low-Dose Parenteral Soybean Oil for the Prevention of Parenteral Nutrition-Associated Liver Disease in Neonates With Gastrointestinal Disorders.
    Calkins KL, Havranek T, Kelley-Quon LI, Cerny L, Flores M, Grogan T, Shew SB.
    JPEN J Parenter Enteral Nutr; 2017 Mar; 41(3):404-411. PubMed ID: 26024828
    [Abstract] [Full Text] [Related]

  • 13. Lipid emulsions in the treatment and prevention of parenteral nutrition-associated liver disease in infants and children.
    Nandivada P, Fell GL, Gura KM, Puder M.
    Am J Clin Nutr; 2016 Feb; 103(2):629S-34S. PubMed ID: 26791189
    [Abstract] [Full Text] [Related]

  • 14. Treatment of parenteral nutrition-associated liver disease: the role of lipid emulsions.
    Nandivada P, Carlson SJ, Chang MI, Cowan E, Gura KM, Puder M.
    Adv Nutr; 2013 Nov; 4(6):711-7. PubMed ID: 24228202
    [Abstract] [Full Text] [Related]

  • 15. Improved outcome in neonatal short bowel syndrome using parenteral fish oil in combination with ω-6/9 lipid emulsions.
    Angsten G, Finkel Y, Lucas S, Kassa AM, Paulsson M, Lilja HE.
    JPEN J Parenter Enteral Nutr; 2012 Sep; 36(5):587-95. PubMed ID: 22275330
    [Abstract] [Full Text] [Related]

  • 16. The use of Omegaven in treating parenteral nutrition-associated liver disease.
    Park KT, Nespor C, Kerner J.
    J Perinatol; 2011 Apr; 31 Suppl 1():S57-60. PubMed ID: 21448206
    [Abstract] [Full Text] [Related]

  • 17. Parenteral nutrition-associated liver disease and lipid emulsions.
    Zugasti Murillo A, Petrina Jáuregui E, Elizondo Armendáriz J.
    Endocrinol Nutr; 2015 Apr; 62(6):285-9. PubMed ID: 25982234
    [Abstract] [Full Text] [Related]

  • 18. Fish oil-based lipid emulsion in the treatment of parenteral nutrition-associated liver disease.
    Cowan E, Nandivada P, Puder M.
    Curr Opin Pediatr; 2013 Apr; 25(2):193-200. PubMed ID: 23407182
    [Abstract] [Full Text] [Related]

  • 19. Development of Parenteral Nutrition-Associated Liver Disease and Other Adverse Effects in Neonates Receiving SMOFlipid or Intralipid.
    Stramara L, Hernandez L, Bloom BT, Durham C.
    JPEN J Parenter Enteral Nutr; 2020 Nov; 44(8):1530-1534. PubMed ID: 32027047
    [Abstract] [Full Text] [Related]

  • 20. The evolving use of intravenous lipid emulsions in the neonatal intensive care unit.
    Calkins KL, Puder M, Gura K.
    Semin Perinatol; 2019 Nov; 43(7):151155. PubMed ID: 31331633
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.